MICHAEL F COLA Insider Trading
Get free email notifications about insider trading for MICHAEL F COLA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL F COLA. MICHAEL F COLA is a Group President, Life Sciences in SAFEGUARD SCIENTIFICS INC ($SFE) and a Managing Director in SAFEGUARD SCIENTIFICS INC ($SFE) and an Chief Executive Officer in Aevi Genomic Medicine, LLC ($GNMX) and a President and CEO in MEDGENICS, INC. ($MDGN) and a Director in Vanda Pharmaceuticals Inc. ($VNDA) and an Chief Executive Officer in Cerecor Inc. ($CERC) and a in Sage Therapeutics, Inc. ($SAGE) and a Director in Phathom Pharmaceuticals, Inc. ($PHAT).
Address: 800 THE SAFEGUARD BUILDING 435 DEVON PARK DRIVE WAYNE 19087-1945 PA
Companies in which MICHAEL F COLA is an Insider
Aevi Genomic Medicine, LLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL F COLA: Chief Executive Officer, President and CEO
Holdings: 175,746 shares
Latest Transaction: Jun 11 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cerecor Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL F COLA: Chief Executive Officer
Holdings: 175,746 shares
Current Value: $145,869
Latest Transaction: Jan 28 2021
$CERC Market Capitalization: $7.38M
$CERC Previous Close: $0.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Phathom Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL F COLA: Director
Holdings: 0 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SAFEGUARD SCIENTIFICS INC
Industry: INVESTORS, NEC [6799]
Position of MICHAEL F COLA: Group President, Life Sciences, Managing Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 17 2004
$SFE Market Capitalization: $246.90M
$SFE Previous Close: $12.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sage Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL F COLA:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 11 2020
$SAGE Market Capitalization: $1.75B
$SAGE Previous Close: $47.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Vanda Pharmaceuticals Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL F COLA: Director
Holdings: 15,000 shares
Current Value: $204,750
Latest Transaction: Jun 17 2019
$VNDA Market Capitalization: $628.43M
$VNDA Previous Close: $13.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL F COLA
Sentiment: All, GNMX, CERC, PHAT, SFE, SAGE, VNDA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2021 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 3.32 | 850,000 | 2,822,000 | 850,000 | |
| Jan 06 2021 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.64 | 64,798 | 171,067 | 64,798 | |
| Oct 02 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.24 | 76,674 | 171,750 | 76,674 | |
| Jul 06 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.56 | 64,683 | 165,588 | 64,683 | |
| Jun 22 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Option Exercise | A | 2.51 | 84,322 | 211,648 | 84,322 | |
| Jun 11 2020 | CERC | Cerecor Inc. | COLA MICHAEL F | Chief Executive Off ... | Buy | P | 2.50 | 100,000 | 250,000 | 175,746 | 75.7 K to 175.7 K (+132.02 %) |
| Jun 11 2020 | GNMX | Aevi Genomic Medic ... | COLA MICHAEL F | Chief Executive Off ... | Buy | P | 2.50 | 100,000 | 250,000 | 175,746 | 75.7 K to 175.7 K (+132.02 %) |